San Francisco, CA, United States of America

Katie Kobara

This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Natera, Inc.. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Katie Kobara. Retrieved from https://idiyas.com/inventor/katie-kobara

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 1 

Average Co-Inventor Count = 1.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Katie Kobara and Prenatal Aneuploidy Risk Assessment.

Introduction

Katie Kobara is an inventor associated with Natera, Inc. Her patent work addresses the use of fetal DNA measurements to assess aneuploidy risk in prenatal testing.

Latest Patents

Kobara is associated with 1 patent, titled “Systems and Methods for Determining Aneuploidy Risk Using Sample Fetal Fraction.” The invention describes systems, methods, and software for estimating aneuploidy risk in a maternal blood or plasma sample using the amount of fetal DNA. It uses genetic data from prior prenatal testing samples and a target sample to determine a fetal fraction distribution based on gestational age and maternal weight. A model derived from that distribution is used to calculate fetal-fraction-based likelihoods for different ploidy states. The method then combines those likelihoods with a previously determined risk score through Bayesian probability to produce an aneuploidy risk score.

Career Highlights

Kobara’s listed patent reflects work in prenatal genetic testing and statistical methods for interpreting fetal DNA data. The disclosed approach incorporates sample characteristics and prior risk information into its assessment.

Collaborations

Kobara is associated with Natera, Inc. Her listed coworkers include Allison Ryan and Zachary Demko.

Conclusion

Katie Kobara’s patent work focuses on combining fetal fraction data and Bayesian analysis to support aneuploidy risk assessment in prenatal testing.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…